Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy

BACKGROUND: Cardiac allograft vasculopathy is a major cause of cardiac allograft rejection. Percutaneous coronary intervention has become the main form of treatment of significant focal lesions. Despite the significance of the problem, data remain scarce. With a large population of transplant recipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyka, Łukasz, Hawranek, Michał, Szyguła-Jurkiewicz, Bożena, Desperak, Piotr, Szczurek, Wioletta, Lekston, Andrzej, Gąsior, Mariusz, Zembala, Michał O., Pawlak, Szymon, Zembala, Marian, Przybyłowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163333/
https://www.ncbi.nlm.nih.gov/pubmed/32253369
http://dx.doi.org/10.12659/AOT.921266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163333/
https://www.ncbi.nlm.nih.gov/pubmed/32253369
http://dx.doi.org/10.12659/AOT.921266

Ejemplares similares